Effects of substance P on headache induction and arterial dilation in healthy adults
Cephalalgia · 2025
DOI: 10.1177/03331024251336132 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cephalalgia, 2025. Verfasst von Haidar M Al-Khazali und 7 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Substance P, Headache, Vasodilation, Temporal Arteries. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lundbeck Foundation.
Abstract (Originalsprache)
Objective
To determine whether intravenous infusion of substance P elicits headache and arterial dilation in healthy adults.
Methods
In a double-blind, placebo-controlled, two-way crossover study, we randomly allocated healthy adults to receive either substance P (1.5 pmol/kg/min) or placebo (isotonic saline) by 20-minute intravenous infusion on separate experiment days. The primary endpoint was the incidence of headache within 12 hours after the infusion. Other endpoints included the area under the curve (AUC) for headache intensity scores over the 12-hour observation period and AUC changes in the superficial temporal artery (STA) diameter from baseline to 120 minutes post-infusion.
Results
Twenty-one participants underwent randomization and completed both experiment days. Headache was reported by 15 (71%) of 21 participants following substance P, compared with two (10%) after placebo ( p < 0.001). The AUC for headache intensity scores was significantly higher after substance P infusion than after placebo ( p = 0.03). In addition, there was a significant STA diameter increase with substance P, compared with placebo ( p = 0.005).
Conclusions
Among healthy adults, substance P infusion elicited headache and arterial dilation. These findings support a role for substance P in headache pathogenesis and encourage further investigation in migraine and other headache disorders. Additional research is also needed to explore new therapeutic strategies targeting substance P or its downstream signaling. Trial Registration: CT identifier: NCT06632080.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Research Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Haidar M Al-Khazali, Rune H Christensen, Emil Gozalov, Rogelio Dominguez-Moreno, Messoud Ashina, Håkan Ashina
Förderung
- Lundbeck Foundation
Zitieren
APA
Al-Khazali, H. M., Christensen, R. H., Gozalov, E., Hakimzadeh, Z., Melchior, A. G., Dominguez-Moreno, R., Ashina, M., & Ashina, H. (2025). Effects of substance P on headache induction and arterial dilation in healthy adults. Cephalalgia. https://doi.org/10.1177/03331024251336132
Vancouver
Al-Khazali HM, Christensen RH, Gozalov E, Hakimzadeh Z, Melchior AG, Dominguez-Moreno R, et al. Effects of substance P on headache induction and arterial dilation in healthy adults. Cephalalgia. 2025. doi:10.1177/03331024251336132
BibTeX
@article{AlKhazali2025,
author = {Al-Khazali, Haidar M and Christensen, Rune H and Gozalov, Emil and Hakimzadeh, Zahra and Melchior, Anna G and Dominguez-Moreno, Rogelio and Ashina, Messoud and Ashina, Håkan},
title = {Effects of substance P on headache induction and arterial dilation in healthy adults},
journal = {Cephalalgia},
year = {2025},
doi = {10.1177/03331024251336132}
}
EUVIMED